| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Bottom |
| Cognigen Corporation - Posters and Presentations : Pre-2006 : 2002 : ASCPT 2002 : Population Modeling to Guide Phase 3 Dose Selection for AC2993 (Synthetic Exendin-4) | published Mon, Nov 10, 2008 - 15:27 EST |
Primary Author: Luann Phillips
Primary Author: Luann Phillips, MBMA
Sponsor: Amylin Pharmaceuticals, Inc.
Event: ASCPT in Atlanta, GA - March 2002
Other Contributors:
Amylin: M. Fineman, BS; K. Taylor, PhD; A. Baron, MD
Cognigen: E. Ludwig, Pharm.D.; T. Grasela, Pharm.D., Ph.D.
| Cognigen Corporation - Posters and Presentations : Pre-2006 : 2002 : ASCPT 2002 : Population Modeling to Guide Phase 3 Dose Selection for AC2993 (Synthetic Exendin-4) | published Mon, Nov 10, 2008 - 15:27 EST |
| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Top |